Morbid obesity - The new pandemic: Medical and surgical management, and implications for the practicing gastroenterologist

Clinical and Translational Gastroenterology

Volumn 4, Issue , 2013, Pages

  Cello, John P ^a   Rogers, Stanley J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; COLON DISEASE; CONSENSUS; DISEASE ASSOCIATION; DISEASE MANAGEMENT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; GASTROENTEROLOGY; GASTROJEJUNOSTOMY; HEPATOBILIARY DISEASE; HUMAN; MEDICAL PRACTICE; MORBID OBESITY; MORBIDITY; MORTALITY; NUTRITIONAL DEFICIENCY; PANDEMIC; PREVALENCE; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; STOMACH SURGERY; SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; UNITED STATES;

EID: 84879974630     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2013.6     Document Type: Review

References (63)

1. Cheung WW, Mao P. Recent advances in obesity: genetics and beyond. Endocrinology 2012; 2247.
2. Samper-Ternent R, Al Snih S. Obesity in older adults: epidemiology and implications for disability and disease. Rev Clin Gerontol 2012; 22: 10-34.
3. Shea J, Diamandis EP, Sharma AM et al. The obesity epidemic. Clin Chem 2012; 58: 968-973.
4. Noël PH, Copeland LA, Pugh MJ et al. Obesity diagnosis and care practices in the Veterans Health Administration. J Gen Intern Med 2010; 25: 510-516.
5. Lockman J, Steelman J. Diagnoses of overweight children and adolescents seen in a pediatric endocrinology clinic. J Pediatr Endocrinol Metab 2008; 21: 221-224. (Pubitemid 351559858)
6. Chugh PK, Sharma S. Recent advances in the pathophysiology and pharmacological treatment of obesity. J Clin Pharm Ther 2012; 10: 1365-2710.
7. Schamroth CL. The perils of pharmacological treatment for obesity: a case of sibutramineassociated cardiomyopathy and malignant arrhythmias. Cardiovasc J Afr 2012; 12: 23.
8. Derosa G, Maffioli P. Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 2012; 11: 459-471.
9. Burch J, McKenna C, Palmer S et al. Rimonabant for the treatment of overweight and obese people. Health Technol Assess 2009; 13(Suppl 3): 13-22.
10. Li M, Cheung BM. Pharmacotherapy for obesity. Br J Clin Pharmacol 2009; 68: 804-810.
11. Florentin M, Kostapanos MS, Nakou ES et al. Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia. J Cardiovasc Pharmacol Ther 2009; 14: 274-282.
12. Johansson K, Neovius K, DeSantis SM et al. Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. Obes Rev 2009; 10: 564-575.
13. Buchwald H, Buchwald JN. Evolution of operative procedures for the management of morbid obesity 1950-2000. Obes Surg 2002; 12: 705-717. (Pubitemid 35305755)
14. Kendrick ML, Dakin GF. Surgical approaches to obesity. Mayo Clin Proc 2006; 81: 18-24.
15. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004; 14: 1157-1164. (Pubitemid 39458587)
16. Jones KB Jr. Bariatric surgery-where do we go from here? Int Surg 2004; 89: 51-57.
17. Victorzon M. An update on sleeve gastrectomy. Minerva Chir 2012; 67: 153-164.
18. Helmiö M, Victorzon M, Ovaska J et al. SLEEVEPASS: A randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc 2012; 26: 2521-2526.
19. Lemanu DP, Srinivasa S, Singh PP et al. Single-stage laparoscopic sleeve gastrectomy: Safety and efficacy in the super-obese. J Surg Res 2012; 177: 49-54.
20. ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis 2012; 8: e21-e26.
21. Arthurs S, Abrahamian Y, Loughren EL et al. New technology review process: the laparoscopic adjustable gastric band. Perm J 2011; 15: 54-60.
22. Cywes R, Bhoyrul S, Billy H et al. APEX Study Group. Interim results at 48 weeks of LAP-BAND AP experience (APEX) study: prospective, multicenter, open-label longitudinal patient observational study. Surg Obes Relat Dis 2011; 8: 741-746.
23. Ponce J, Lindsey B, Pritchett S et al. New adjustable gastric bands available in the United States: a comparative study. Surg Obes Relat Dis 2011; 7: 74-79.
24. Ayloo S, Bueno R. Band erosion: laparoscopic removal of lap-band. Surg Endosc 2009; 23: 657-658.
25. Cunneen SA. Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2008; 4: S47-S55. (Pubitemid 351689962)
26. Busetto L, Angrisani L, Basso N et al. Italian Group for Lap-Band. Safety and efficacy of laparoscopic adjustable gastric banding in the elderly. Obesity (Silver Spring) 2008; 16: 334-338. (Pubitemid 351271913)
27. Chakravarty PD, McLaughlin E, Whittaker D et al. Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 2012; 10: 172-182.
28. Ramón JM, Salvans S, Crous X et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg 2012; 16: 1116-1122.
29. Sugerman HJ. Bariatric surgery for severe obesity. Proc Am Philos Soc 2011; 155: 263-275.
30. Herron D, Roohipour R. Complications of Roux-en-Y gastric bypass and sleeve gastrectomy. Abdom Imaging 2012; 37: 712-718.
31. Boza C, Gamboa C, Salinas J et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up. Surg Obes Relat Dis 2011; 8: 243-249.
32. Romy S, Donadini A, Giusti V et al. Roux-en-Y gastric bypass vs gastric banding for morbid obesity: a case-matched study of 442 patients. Arch Surg 2012; 147: 460-466.
33. Spivak H, Abdelmelek MF, Beltran OR et al. Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc 2012; 26: 1909-1919.
34. Frank P, Crookes PF. Short- and long-term surgical follow-up of the postbariatric surgery patient. Gastroenterol Clin North Am 2010; 39: 135-146.
35. Coupaye M, Puchaux K, Bogard C et al. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg 2009; 19: 56-65.
36. Lynch RJ, Eisenberg D, Bell RL. Metabolic consequences of bariatric surgery. J Clin Gastroenterol 2006; 40: 659-668. (Pubitemid 44350584)
37. Mango VL, Frishman WH. Physiologic, psychologic, and metabolic consequences of bariatric surgery. Cardiol Rev 2006; 14: 232-237. (Pubitemid 44298021)
38. Ledoux S, Msika S, Moussa F et al. Comparison of nutritional consequences of conventional therapy of obesity, adjustable gastric banding, and gastric bypass. Obes Surg 2006; 16: 1041-1049. (Pubitemid 44221270)
39. Richardson DW, Vinik AI. Metabolic implications of obesity: before and after gastric bypass. Gastroenterol Clin North Am 2005; 34: 9-24. (Pubitemid 40488728)
40. Rojas P, Carrasco F, Codoceo J et al. Trace element status and inflammation parameters after 6 months of Roux-en-Y gastric bypass. Obes Surg 2011; 21: 561-568.
41. Takata MC, Ciovica R, Cello JP et al. Predictors, treatment, and outcomes of gastrojejunostomy stricture after gastric bypass for morbid obesity. Obes Surg 2007; 17: 878-884. (Pubitemid 350042914)
42. Carter JT, Tafreshian S, Campos GM et al. Routine upper GI series after gastric bypass does not reliably identify anastomotic leaks or predict stricture formation. Surg Endosc 2007; 21: 2172-2177. (Pubitemid 350125936)
43. Al Harakeh AB. Complications of laparoscopic Roux-en-Y gastric bypass. Surg Clin North Am 2011; 91: 1225-1237.
44. Azagury DE, Abu Dayyeh BK, Greenwalt IT et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy 2011; 43: 950-954.
45. Hamdan K, Somers S, Chand M. Management of late postoperative complications of bariatric surgery. Br J Surg 2011; 98: 1345-1355.
46. Heneghan HM, Meron-Eldar S, Yenumula P et al. Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese. Surg Obes Relat Dis 2011; 8: 729-735.
47. Ferreira LE, Song LM, Baron TH. Management of acute postoperative hemorrhage in the bariatric patient. Gastrointest Endosc Clin N Am 2011; 21: 287-294.
48. Rabl C, Peeva S, Prado K et al. Early and late abdominal bleeding after Roux-en-Y gastric bypass: sources and tailored therapeutic strategies. Obes Surg 2011; 21: 413-420.
49. Cingi A, Yavuz Y. Intraoperative endoscopic assessment of the pouch and anastomosis during laparoscopic Roux-en-Y gastric bypass. Obes Surg 2011; 21: 1530-1534.
50. Puri V, Alagappan A, Rubin M et al. Management of bleeding from gastric remnant after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2012; 8: 3-5.
51. Dick A, Byrne TK, Baker M et al. Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe? Surg Obes Relat Dis 2010; 6: 643-647.
52. Frantzides CT, Carlson MA, Shostrom VK et al. A survey of dumping symptomatology after gastric bypass with or without lesser omental transection. Obes Surg 2011; 21: 186-193.
53. Hejazi RA, Patil H, McCallum RW. Dumping syndrome: establishing criteria for diagnosis and identifying new etiologies. Dig Dis Sci 2010; 55: 117-123.
54. Padoin AV, Galvão Neto M, Moretto M et al. Obese patients with type 2 diabetes submitted to banded gastric bypass: greater incidence of dumping syndrome. Obes Surg 2009; 19: 1481-1484.
55. Deitel M. The change in the dumping syndrome concept. Obes Surg 2008; 18: 1622-1624.
56. Z'graggen K, Guweidhi A, Steffen R et al. Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg 2008; 18: 981-988.
57. Falcão M, Campos JM, Neto MG et al. Transgastric endoscopic retrograde cholangiopancreatography for the management of biliary tract disease after Roux-en-Y gastric bypass treatment for obesity. Obes Surg 2012; 22: 872-876.
58. Madan A, Urayama S. Successful ERCP in a Roux-en-Y gastric bypass patient, performed via a small remnant of gastrogastric communication. Endoscopy 2011; 43(Suppl): E73-E74.
59. Geert P, Jacques H, Guido L. ERCP by laparoscopic transgastric access and cholecystectomy at the same time in a patient with gastric bypass who was seen with choledocholithiasis. Gastrointest Endosc 2010; 72: 1115-1116.
60. Malherbe V, Badaoui A, Huybrecht H et al. Management of common bile duct stone late after laparoscopic Roux-en-Y gastric bypass for obesity. Acta Chir Belg 2009; 109: 820-823.
61. Badaoui A, Malherbe V, Rosiere A et al. ERCP by laparoscopic transgastric access and cholecystectomy at the same time in a patient with gastric bypass who was seen with choledocholithiasis. Gastrointest Endosc 2010; 71: 212-214.
62. Peeters G, Himpens J. A hybrid endo-laparoscopic therapy for common bile duct stenosis of a choledocho-duodenostomy after a Roux-en-Y gastric bypass. Obes Surg 2009; 19: 806-808.
63. Ahmed AR, Husain S, Saad N et al. Accessing the common bile duct after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2007; 3: 640-643. (Pubitemid 350091410)